Dermal fillers: FDA adverse event reports by year

How many adverse event reports has FDA received for dermal fillers?

FDA’s MAUDE database holds 23,207 reports under the dermal filler product codes LMH and PKY (openFDA data updated November 4, 2026), 1,825 of them received in 2025: 19,476 marked Injury, 1,645 marked Malfunction and 15 marked Death by the submitter. Botulinum toxin products are biologic drugs, not devices, so they are not in these counts. A report is not proof the device caused the event. In FDA’s words, “The submission of an MDR itself does not necessarily demonstrate that the device caused or contributed to the adverse outcome or event.”

Counts of FDA MAUDE medical device reports under LMH (dermal implants for aesthetic use) and PKY (for aesthetic use in the hands), by the year FDA received them and the event type the submitter chose. 987 LMH reports have a blank event type. No report text is read or shown, and no report is tied to a clinic.

LMHImplant, Dermal, For Aesthetic Use, class 323,2021519,4711,6452,071
PKYImplant, Dermal, For Aesthetic Use In The Hands, class 350500

Reports by year received

FDA says “MDR data is not intended to be used either to evaluate rates of adverse events, evaluate a change in event rates over time, or to compare adverse event occurrence rates across devices.”

2026 (part year)1,75031,737550
20251,82511,819500
20241,39301,386700
20231,47811,471510
20221,35901,350801
20211,42211,413800
20201,15611,1451000
20191,27321,15411502
20181,80411,14066300
20171,510195755200
20166910687400
201588618516208
201478626934834
2013451034101055
20124020262012614
20114490269214434
201073204851518547
20091,21712694158785
200830801701910712
2007175010019524
200613108610278
2005130067132030
2004163012414214
2003217017431102
200219001542655
200115401271449
200020001583516
199926302451710
199829102711811
19972930276980
1996102094701
1995100001
1994401003
1993100001

Brand names on LMH reports

SCULPTRA1,602
JUVEDERM VOLUMA XC/LIDO (VOLUME UNKNOWN)1,088
JUVEDERM VOLUMA XC 27G 2 X 1ML885
JUVEDERM ULTRA XC TSK US682
UNK VOLBELLA676
VOLBELLA WITH LIDOCAINE640
JUVEDERM VOLUMA WITH LIDOCAINE 1ML620
RADIESSE DERMAL FILLER596
JUVEDERM (VOLUME/CONCENTRATION/ADDITIVE UNKNOWN)506
JUVEDERM ULTRA PLUS XC TSK US494
ZYPLAST COLLAGEN IMPLANT467
UNK JUVEDERM VOLUX462
VOLIFT WITH LIDOCAINE456
RADIESSE INJECTABLE IMPLANT441
JUVEDERM VOLUMA (VOLUME/ADDITIVE UNKNOWN)428
JUVEDERM VOLLURE XC 2X1 ML424
VOLIFT (VOLUME UNKNOWN)414
JUVEDERM VOLUMA WITH LIDOCAINE 1ML SKU1346
SCULPTRA (POLY-L-LACTIC ACID)283
BELOTERO BALANCE252

Manufacturer names and every code: dermal filler device reports.

FDA’s own description of the limits of these reports, quoted from its MAUDE database page:

Common questions

Are Botox reports included?

No. Botulinum toxin products are regulated as biologic drugs, and their adverse events are reported to FDA’s drug reporting system (FAERS), not MAUDE.

Does a report mean a filler caused the problem described?

No. FDA says “The submission of an MDR itself does not necessarily demonstrate that the device caused or contributed to the adverse outcome or event.”

Why does one brand appear under several names?

Names are shown as submitters wrote them, including volume, needle size or “unknown” prefixes, and are not merged.

Sources

Records last pulled Nov 11, 2026. Every entry links to the original public record.

This page counts FDA medical device reports as openFDA publishes them, by product code. A report is a submitter’s account of an event, not proof the device caused it; FDA says “The submission of an MDR itself does not necessarily demonstrate that the device caused or contributed to the adverse outcome or event.” Reports are not tied to any clinic listed here, and report narratives are not republished. Report an error or add a company response.